Addus HomeCare (NASDAQ:ADUS) issued its earnings results on Sunday. The company reported $0.74 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.74, MarketWatch Earnings reports. The business had revenue of $205.30 million for the quarter, compared to analyst estimates of $209.70 million. Addus HomeCare had a net margin of 4.65% and a return on equity of 8.90%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period last year, the company posted $0.77 earnings per share.
ADUS stock traded down $6.24 during trading on Tuesday, hitting $98.83. 382,011 shares of the company’s stock traded hands, compared to its average volume of 91,031. The business has a fifty day simple moving average of $107.10 and a two-hundred day simple moving average of $109.29. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.19 and a current ratio of 3.19. Addus HomeCare has a 1 year low of $77.61 and a 1 year high of $129.01.
In other Addus HomeCare news, EVP Laurie Manning sold 1,035 shares of Addus HomeCare stock in a transaction on Wednesday, March 3rd. The shares were sold at an average price of $102.00, for a total value of $105,570.00. Also, CEO R Dirk Allison sold 5,539 shares of Addus HomeCare stock in a transaction on Wednesday, March 3rd. The stock was sold at an average price of $102.09, for a total transaction of $565,476.51. Over the last three months, insiders have sold 11,888 shares of company stock worth $1,223,430. 6.90% of the stock is currently owned by corporate insiders.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.